RAPP Earnings

Quarterly EPS
$-0.50
Q3 2024
$-0.56
Q4 2024
$-0.68
Q1 2025
$-0.75
Q2 2025
$-0.71
Q3 2025
$-0.72
Q4 2025
$-0.42
Q1 2026
$-1.19
Q2 2026
Latest RevenueN/A
Latest Net Income-56615000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.190-56615000—-58.7%
Q1 2026-$0.4220.0M-19857000—+38.2%
Q4 2025-$0.720-33763000—-28.6%
Q3 2025-$0.710-26925000—-42.0%
Q2 2025-$0.750-26732000—+55.9%
Q1 2025-$0.680-24063000——
Q4 2024-$0.560-19980000——
Q3 2024-$0.500-17537000——
Q2 2024-$1.700-18121000——
Rapport Therapeutics (RAPP) — Earnings